Furthermore, immunoblotting analysis of lysates prepared from either tumors or adjacent normal tissues from five melanoma patients showed a close correlation between the extent of MCL1 upregulation and the level of mTORC1 signaling in those tumors, further confirming the association between both oncogenic events (Fig. 1H). The gene discussed is MCL1; the disease is melanoma.